{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T20:53:25Z","timestamp":1783630405142,"version":"3.55.0"},"reference-count":18,"publisher":"Wiley","issue":"5","license":[{"start":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T00:00:00Z","timestamp":1778544000000},"content-version":"vor","delay-in-days":11,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["J Biochem &amp;amp; Molecular Tox"],"published-print":{"date-parts":[[2026,5]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:sec>\n                    <jats:label\/>\n                    <jats:p>Alcoholic fatty liver disease (AFLD) is a progressive hepatic pathology triggered by chronic ethanol consumption, serving as the initial stage of severe liver injury. Currently, there are no Food and Drug Administration (FDA)\u2010approved pharmacological interventions that specifically target alcohol\u2010induced hepatic steatosis or prevent disease progression, highlighting an urgent need for effective preventive strategies. This study evaluated the preventive efficacy and underlying mechanisms of Ergothioneine (EGT) in a clinically relevant preclinical model. C57BL\/6 mice were randomized into five groups: a Control group, an alcoholic fatty liver Model group, a Positive control group treated with Silybin (100\u2009mg\/kg), and three EGT treatment groups (10, 30, and 50\u2009mg\/kg). The National Institute on Alcohol Abuse and Alcoholism (NIAAA) mouse model was utilized to induce alcoholic fatty liver. Various biochemical, histological, and molecular markers were assessed to evaluate liver damage, alcohol metabolism, lipid profiles, oxidative stress, and inflammation. EGT treatment significantly ameliorated hepatic steatosis and necrosis, as confirmed by Hematoxylin and Eosin (H&amp;E) and Oil Red O staining. Notably, EGT accelerated alcohol clearance, reducing serum ethanol levels by up to 54.4% in a dose\u2010dependent manner. Furthermore, EGT restored liver function markers, including alanine aminotransferase (ALT), aspartate aminotransferase (AST), and gamma\u2010glutamyl transferase (GGT), and corrected dyslipidemia by lowering triglycerides (TG), total cholesterol (TC), and low\u2010density lipoprotein cholesterol (LDL\u2010C) while elevating high\u2010density lipoprotein cholesterol (HDL\u2010C). Mechanistically, EGT suppressed pro\u2010inflammatory cytokines (Interleukin\u20106 [IL\u20106], Interleukin\u20101 beta [IL\u20101\u03b2]) and mitigated oxidative stress by reducing malondialdehyde (MDA) accumulation and restoring superoxide dismutase (SOD) and glutathione peroxidase (GSH\u2010Px) activities. Ergothioneine prevents alcoholic liver injury through a dual mechanism: accelerating ethanol metabolism and enhancing hepatocyte antioxidative and anti\u2010inflammatory defenses. These findings position EGT as a promising therapeutic candidate for AFLD management.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1002\/jbt.70899","type":"journal-article","created":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T04:45:01Z","timestamp":1778647501000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Ergothioneine Ameliorates Alcoholic Fatty Liver Disease: A Dual Strategy of Accelerated Ethanol Elimination and Reducing Oxidative Stress"],"prefix":"10.1002","volume":"40","author":[{"given":"Wei","family":"Ding","sequence":"first","affiliation":[{"name":"Gene III Biotechnology Co. Ltd. Nanjing Jiangsu Province China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Cao","sequence":"additional","affiliation":[{"name":"Gene III Biotechnology Co. Ltd. Nanjing Jiangsu Province China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cong","family":"Guo","sequence":"additional","affiliation":[{"name":"Gene III Biotechnology Co. Ltd. Nanjing Jiangsu Province China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xu","family":"Li","sequence":"additional","affiliation":[{"name":"Gene III Biotechnology Co. Ltd. Nanjing Jiangsu Province China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Liu","sequence":"additional","affiliation":[{"name":"Gene III Biotechnology Co. Ltd. Nanjing Jiangsu Province China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-3245-4359","authenticated-orcid":false,"given":"Guohua","family":"Xiao","sequence":"additional","affiliation":[{"name":"Gene III Biotechnology Co. Ltd. Nanjing Jiangsu Province China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2026,5,12]]},"reference":[{"key":"e_1_2_9_2_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12986-021-00554-3"},{"key":"e_1_2_9_3_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0183426"},{"key":"e_1_2_9_4_1","doi-asserted-by":"publisher","DOI":"10.4062\/biomolther.2016.176"},{"key":"e_1_2_9_5_1","doi-asserted-by":"publisher","DOI":"10.3892\/ijmm.2017.3095"},{"issue":"7","key":"e_1_2_9_6_1","first-page":"6147","article-title":"Poria Cocos Polysaccharides Improve Alcoholic Liver Disease by Interfering With Ferroptosis Through NRF2 Regulation","volume":"16","author":"Zhou X.","year":"2024","journal-title":"Aging"},{"key":"e_1_2_9_7_1","doi-asserted-by":"publisher","DOI":"10.3389\/fnut.2022.1053718"},{"key":"e_1_2_9_8_1","doi-asserted-by":"publisher","DOI":"10.3390\/nu14030658"},{"key":"e_1_2_9_9_1","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2024.1432480"},{"issue":"11","key":"e_1_2_9_10_1","first-page":"82","article-title":"Esculentoside A Inhibits Ethyl Alcohol\u2010Induced Lipid Accumulation and Oxidative Stress in Hepatocytes by Activating the AMPK Pathway","volume":"19","author":"Tang Z.","year":"2023","journal-title":"Journal of Men's Health"},{"key":"e_1_2_9_11_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12944-024-02382-9"},{"key":"e_1_2_9_12_1","doi-asserted-by":"publisher","DOI":"10.1002\/jat.4728"},{"key":"e_1_2_9_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cld.2012.08.002"},{"key":"e_1_2_9_14_1","doi-asserted-by":"publisher","DOI":"10.1017\/S0007114522003592"},{"key":"e_1_2_9_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2021.101868"},{"key":"e_1_2_9_16_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12906-025-04949-0"},{"key":"e_1_2_9_17_1","doi-asserted-by":"publisher","DOI":"10.3390\/ijms161125942"},{"key":"e_1_2_9_18_1","doi-asserted-by":"publisher","DOI":"10.4254\/wjh.v12.i7.332"},{"key":"e_1_2_9_19_1","doi-asserted-by":"publisher","DOI":"10.1002\/1873-3468.14269"}],"container-title":["Journal of Biochemical and Molecular Toxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/jbt.70899","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1002\/jbt.70899","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/jbt.70899","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T16:20:17Z","timestamp":1778862017000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/jbt.70899"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":18,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["10.1002\/jbt.70899"],"URL":"https:\/\/doi.org\/10.1002\/jbt.70899","archive":["Portico"],"relation":{},"ISSN":["1095-6670","1099-0461"],"issn-type":[{"value":"1095-6670","type":"print"},{"value":"1099-0461","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"2026-03-02","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-05-06","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-05-12","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e70899"}}